Clinical Trial Update: Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis [Phase 4]

View source ↗

Summary

This Phase 4 update reports completion of a study evaluating the safety and efficacy of intramuscular paromomycin for visceral leishmaniasis and expanding acces…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• Paromomycin IM Injection (Paromomycin)

Snippet

Sponsor: PATH | Conditions: Visceral Leishmaniasis | Phase 4 | Status: COMPLETED